home.aspx
 
EVENTS

Internal Medicine for Primary Care
INTERNAL MEDICINE FOR PRIMARY CARE
October 30-01, 2020
The Internal Medicine for Primary Care conference will cover areas like Internal Medicine for Primary Care Physicians, Issues in Women's Health Cardio, Pulmonary for Primary Care Physicians, Neurology for the Non-Neurologist.

Symposium on Advanced Wound Care Fall
SYMPOSIUM ON ADVANCED WOUND CARE FALL
October 30-01, 2020
The Symposium on Advanced Wound Care Fall meeting (SAWC Fall) serves as a forum to connect the entire wound care team — physicians, nurses, physical therapists, researchers, scientists, podiatrists, and dietitians — with the foremost experts in wound care to improve patient outcomes thro...

Azurity Pharmaceuticals

SHARESHARESHARE
CutisPharma, Inc., based in Wilmington, MA, is a privately held, specialty pharmaceutical company focusing on the development and commercialization of value-added proprietary drug products and technologies in the prescription compounding sector of the pharmaceutical industry. Product line and development efforts initially are focused on providing optimized, more efficient alternatives for the preparation of the nearly 10 million currently compounded prescriptions, by offering FIRST® Unit-of-Use Prescription Compounding Kits. Use of these branded compounding kits will be beneficial to all triad participants, namely physicians, pharmacists, and patients. Three U.S. patents have been issued to the Company with several additional patents pending.
SHARESHARESHARE

RELATED NEWS


Digital pathology startup Deep Lens has unveiled an artificial intelligence (AI) platform that will enable pathologists to diagnose cancer patients more swiftly and accurately. The Ohio-based company has secured early funding worth $3.2m for Virtual Imaging for Pathology Education and Research (VIPER).
The platform uses advanced AI to conduct certain monotonous diagnostic tests instantaneously. This allows diagnoses to be made speedily. VIPER can also help pathologists to match patients w...


READ MORE

Eli Lilly has filed a new migraine drug, lasmiditan, with the US regulator, the first drug in its class to be reviewed as a treatment for the condition. The US pharma added that the regulator has granted its Emgality (galcanezumab) Breakthrough Designation for prevention of episodic cluster headache, building on a previous approval in another form of migraine. An oral drug, lasmiditan is a selective serotonin 5-HT1F agonist that Lilly says is distinct from other approved migraine therapies and d...

READ MORE

Granules India has reported a 38 per cent increase in net profit at Rs 45.67 crore in the January-March quarter this year as against Rs 34.1 crore in the same quarter last year. Profits have accrued due to decrease in costs, among other factors....

READ MORE

London, UK-based Heptares Therapeutics says the first healthy subject has now been dosed with its first-in-class, selective muscarinic M4 receptor agonist HTL0016878 in a Phase I clinical study. The move triggers a $15 million milestone payment from Allergan under a global R&D and commercialization partnership signed in April last year, under which Allergan licensed exclusive global rights to Heptares’ broad portfolio of novel subtype-selective muscarinic receptor agonists for the treatment of m...

READ MORE

The results from the open label phase 2 trial confirm that Rebiotix’s drug, RBX2660, is the frontrunner among a coming wave of new microbiome treatments....

READ MORE

Akorn Pharmaceuticals, which had a $4.3 billion buyout by Fresenius tank last fall, just can’t seem to catch a break. Just weeks after being hit with an FDA warning letter for its manufacturing operations in Illinois—problems that led to the death of the deal—Akorn today reported that it has received a citation on its third U.S. facility While the four observations were relatively minor, it was a downer on the same day the new CEO Douglas Boothe was telling the market Akorn is ...

READ MORE

EVENTS

Vital Signs EMS Conference
VITAL SIGNS EMS CONFERENCE
October 29-01, 2020
Vital Signs EMS Conference will be showcasing many of the extraordinary aspects of EMS and healthcare found only in Saratoga Springs. This event provided high quality and cutting edge EMS education by providing access to national and world-renowned educators through a forum that is accessible and af...

Update CME - Internal Medicine & Primary Care
UPDATE CME - INTERNAL MEDICINE & PRIMARY CARE
October 29-01, 2020
Earn 30 CME Credits by attending our Update CME Internal Medicine and Primary Care Conference either in person or via live stream!Expert speakers from The University of Chicago, Johns Hopkins, and University of California, Los Angeles will be presenting on the latest clinical guidelines. We offer in...